10% Off
Rosen 280.03 mg+3
Incepta Pharmaceuticals Ltd.
৳359.10
Add to cart
Generic medicine
Ethinylestradiol + Drospirenone [For oral contraception]: Brands, Price & Uses in Bangladesh
Ethinylestradiol + Drospirenone [For oral contraception] is a combined oral contraceptive (COC) indicated for the prevention of pregnancy in women who choose to use this method of contraception.
About Ethinylestradiol + Drospirenone [For oral contraception]
Indications of Ethinylestradiol + Drospirenone [For oral contraception]
Ethinylestradiol + Drospirenone [For oral contraception] is a combined oral contraceptive (COC) indicated for the prevention of pregnancy in women who choose to use this method of contraception.
Established/FDA-approved use
- Prevention of pregnancy in women of reproductive age who elect to use oral contraception (the sole approved indication for this bracketed formulation of Ethinylestradiol + Drospirenone [For oral contraception]).
Guideline-supported non-contraceptive benefits (not the primary approved indication of this product, but recognized effects of combined oral contraceptives containing drospirenone)
- Some women using Ethinylestradiol + Drospirenone [For oral contraception] experience improvement in acne and reduction in menstrual blood loss/cycle regularity as a secondary effect of ovulation suppression, though Ethinylestradiol + Drospirenone [For oral contraception] is not indicated as a first-line treatment for acne or heavy menstrual bleeding on its own.
Ethinylestradiol + Drospirenone [For oral contraception] is not indicated for use as a treatment for cancer, as an emergency contraceptive after unprotected intercourse, or for use by men.
Dosage & Administration of Ethinylestradiol + Drospirenone [For oral contraception]
Adult dosing (the only approved population)
| Regimen | Schedule |
|---|---|
| 21-tablet pack | One active tablet daily for 21 days, followed by a 7-day hormone-free interval, then start the next pack. |
| 28-tablet pack | One tablet daily for 28 days in the printed sequence (active tablets followed by placebo tablets), then start the next pack immediately with no interval. |
Administration instructions
- Take Ethinylestradiol + Drospirenone [For oral contraception] at approximately the same time each day, with or without food, to maintain contraceptive effectiveness.
- If starting Ethinylestradiol + Drospirenone [For oral contraception] for the first time, begin on day 1 of the menstrual cycle for immediate contraceptive protection, or use a back-up (barrier) method for the first 7 days if starting on a later day (Sunday-start or other regimens per product labeling).
- If a dose is missed, follow the specific missed-pill instructions in the product package insert; a back-up contraceptive method and/or emergency contraception may be needed depending on how many pills were missed and the point in the cycle.
There is no well-established renal or hepatic dose adjustment for Ethinylestradiol + Drospirenone [For oral contraception]; instead, significant renal or hepatic impairment is a contraindication to use (see Contraindications) because of the risk of hyperkalemia and reduced hormone clearance.
Side Effects of Ethinylestradiol + Drospirenone [For oral contraception]
Common side effects
- Nausea and vomiting
- Headache
- Breast tenderness or pain
- Irregular menstrual bleeding or spotting, particularly in the first few cycles
- Mood changes
- Weight change
Serious side effects
- Venous thromboembolism (deep vein thrombosis, pulmonary embolism)
- Arterial thromboembolism (stroke, myocardial infarction) - risk increased with smoking and age over 35 (see Precautions and Warnings)
- Hyperkalemia, particularly in women with risk factors (see Interactions and Precautions)
- Hypertension
- Gallbladder disease
- Hepatic adenoma (rare)
Seek immediate medical attention for signs of blood clots (leg swelling/pain, chest pain, shortness of breath, sudden severe headache, vision changes, or weakness on one side of the body) while using Ethinylestradiol + Drospirenone [For oral contraception].
Contraindications of Ethinylestradiol + Drospirenone [For oral contraception]
Ethinylestradiol + Drospirenone [For oral contraception] is contraindicated in women with any of the following:
- Known hypersensitivity to ethinylestradiol, drospirenone, or any component of Ethinylestradiol + Drospirenone [For oral contraception]
- Current or past history of deep vein thrombosis or pulmonary embolism
- Current or past history of cerebrovascular disease (stroke) or coronary artery disease
- Valvular heart disease with thrombogenic complications
- Severe or uncontrolled hypertension
- Diabetes mellitus with vascular involvement
- Headache with focal neurologic symptoms, or migraine with aura
- Known or suspected breast cancer or other known or suspected estrogen- or progestin-sensitive cancer
- Undiagnosed abnormal uterine/genital bleeding
- Cholestatic jaundice of pregnancy or jaundice with prior combined hormonal contraceptive use
- Hepatic tumors (benign or malignant) or active liver disease
- Adrenal insufficiency, or renal or hepatic impairment (because drospirenone's antimineralocorticoid activity carries a risk of hyperkalemia in these conditions)
- Pregnancy (known or suspected)
- Heavy smokers (15 or more cigarettes/day) who are age 35 years or older
Frequently Asked Questions about Ethinylestradiol + Drospirenone [For oral contraception]
How does Ethinylestradiol + Drospirenone [For oral contraception] prevent pregnancy?
Ethinylestradiol + Drospirenone [For oral contraception] works mainly by suppressing ovulation, thickening cervical mucus to block sperm, and altering the uterine lining, which together prevent pregnancy when taken as directed.
Can I take Ethinylestradiol + Drospirenone [For oral contraception] if I smoke?
Smoking while using Ethinylestradiol + Drospirenone [For oral contraception] significantly increases the risk of serious cardiovascular events such as blood clots, stroke, and heart attack, especially if you are over 35 years old. Women who use Ethinylestradiol + Drospirenone [For oral contraception] are strongly advised not to smoke.
What should I do if I miss a dose of Ethinylestradiol + Drospirenone [For oral contraception]?
Follow the missed-pill instructions in the product package insert, which vary depending on how many tablets were missed and where you are in the cycle; you may need a back-up contraceptive method or emergency contraception. Contact your physician or pharmacist for guidance.
Is Ethinylestradiol + Drospirenone [For oral contraception] safe to use while breastfeeding?
Combined hormonal contraceptives like Ethinylestradiol + Drospirenone [For oral contraception] can reduce milk supply and are generally not preferred during breastfeeding; a progestin-only method is usually recommended instead. Use Ethinylestradiol + Drospirenone [For oral contraception] during lactation only if clearly needed and after consulting a physician.
Who should not use Ethinylestradiol + Drospirenone [For oral contraception]?
Ethinylestradiol + Drospirenone [For oral contraception] is contraindicated in women with a history of blood clots, stroke, heart disease, uncontrolled high blood pressure, certain migraines, breast or hormone-sensitive cancers, liver disease or liver tumors, adrenal or significant kidney impairment, undiagnosed vaginal bleeding, pregnancy, or in heavy smokers aged 35 or older. A physician should review your full medical history before prescribing Ethinylestradiol + Drospirenone [For oral contraception].
Can Ethinylestradiol + Drospirenone [For oral contraception] cause high potassium levels?
Yes, drospirenone in Ethinylestradiol + Drospirenone [For oral contraception] has antimineralocorticoid activity that can raise blood potassium, particularly in women taking ACE inhibitors, ARBs, potassium-sparing diuretics, or NSAIDs, or those with kidney, liver, or adrenal disease. Your physician may check your potassium level if you have these risk factors.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.